Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2025-06-04 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于控股股东、实际控制人之间内部协议转让股份的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement regarding an internal agreement for the transfer of shares between the company's controlling shareholders and actual controllers. It specifies the share quantities, transfer price, payment terms, legal compliance, and confirms that the transfer does not affect the controlling shareholder status or trigger a public tender offer. The document is a formal disclosure of a share transfer agreement between major shareholders, not a financial report, earnings release, or management report. It is not a regulatory certification or a report publication announcement. The content fits the category of a Major Shareholding Notification (MRQ), as it involves notification of changes in significant share ownership levels, even though the total controlling interest remains unchanged. Therefore, the appropriate classification is MRQ with high confidence.
2025-06-04 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details changes in shareholding percentages and share transfers among major shareholders and related parties. The content includes information about shareholding changes due to convertible bond conversions and internal share transfers between related parties, with no change in total shareholding percentage. It also includes legal declarations, share transfer agreements, and compliance with securities laws. There is no indication of financial statements, earnings data, or management discussion of financial results. The document is a formal notification of changes in major shareholdings and related disclosures as required by securities regulations. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is substantial and contains detailed information, not just an announcement or a brief note, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is MRQ with high confidence.
2025-06-04 Chinese
关于取得专利证书及计算机软件著作权登记证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. about obtaining patent certificates and computer software copyright registration certificates. It details the number and types of patents and copyrights obtained by the company and its subsidiaries, and states that these achievements will not have a significant impact on recent operations but will enhance intellectual property protection and innovation. The document is short (1633 characters) and serves as a formal announcement of these intellectual property achievements rather than a detailed report or financial filing. It does not contain financial data, management changes, voting results, or other report types. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2025-05-29 Chinese
2024年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the implementation of the 2024 annual equity distribution (dividend) plan approved at the 2024 Annual General Meeting (AGM). It details the dividend amount, record date, ex-dividend date, and distribution method. It is not the full annual report or financial statements but a specific announcement about dividend distribution following shareholder approval. The document length is short (1708 characters) and focuses on dividend payment details rather than comprehensive financial data or management discussion. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-05-20 Chinese
2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 Annual General Meeting (AGM) of Zhejiang Tailin Biotechnology Co., Ltd. It includes voting results on various agenda items such as the 2024 annual report, board and supervisory reports, profit distribution, financial statements, auditor appointment, remuneration plans, capital changes, and investment projects. The document also confirms the legality and validity of the meeting and voting process, supported by legal opinions. The content is focused on the official voting results and decisions made at the AGM rather than the full annual report or other detailed financial disclosures. The document length is about 5038 characters, which is sufficient for a detailed voting results announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-19 Chinese
关于与杭州富春湾新城管理委员会签订高性能过滤器及配套功能膜产业化项目合同书暨对外投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a contract for a high-performance filter and membrane industrialization project and the progress of an external investment. It references board and shareholder meetings approving the contract and discusses risks and project details. The document is relatively short (1115 characters) and does not contain financial statements or detailed financial data. It is an update on a capital investment project rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2025-05-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.